Clean Biologics SAS acquires Biodextris Inc.
Exelixis Expands its Biotherapeutics Portfolio with Acquisition of GamaMabs Pharma’s First-in-Class Humanized Antibody Program Against a Novel Oncology Target
Tollys appoints Amina Zinaï, MD, as head of clinical development
Calixar invests €1 Million in pipeline of highly druggable membrane protein targets and native antigens
Domain Therapeutics presents most recent developments of its BRET technology portfolio at AACR and ASPET events
Yposkesi accueille le groupe SK comme nouvel actionnaire majoritaire à son capital et noue ainsi un solide partenariat industriel de croissance
Yposkesi to give talk on gene therapy vectors at Virtual Cell & Gene Meeting on the Mediterranean, April 6 – 9, 2021
Cell-Easy strengthens executive team with two new highly experienced members
